Author Archives: Sara Agee Le

June 3, 2015
Press Release

Atomwise Inc. today announced it has raised $6 million in seed funding from five leading, science-focused venture capital firms: Data Collective, which led the funding, Khosla Ventures, DFJ, AME Cloud Ventures, and OS Fund. “Having any one of these investors behind Atomwise would be remarkable,” said Co-founder and CEO, Dr. Abraham Heifets. “Having all five […]

Read Article
March 24, 2015
Press Release

Four months ago, Atomwise launched a virtual search for safe, existing medicines that could be repurposed to treat the Ebola virus. This week, the first evidence has been found that two drugs predicted by Atomwise’s artificial intelligence technology may significantly reduce Ebola infectivity. These drugs were intended for unrelated illnesses and their potential to treat […]

Read Article
March 24, 2015
In The News

The West African Ebola virus disease epidemic resulted in at least 11,310 deaths according to the World Health Organization. Ebola virus infections were reported across 6 West African countries, as well as in 3 European countries and in the United States, underscoring the potential for a global pandemic…

Read Article
November 4, 2014
Press Release

Atomwise Inc. and the University of Toronto announced today an initiative to search for new treatments for the Ebola virus using artificial intelligence. Deploying a groundbreaking research technology that learns and thinks like a human chemist, the team will use Canada’s most powerful supercomputer to simulate and analyze millions of potential medicines in a matter […]

Read Article